Jun
24
2020
On demand

Challenges of cell collections for cell therapy manufacturing: what do we want in the bag?

Sponsor
Challenges of cell collections for cell therapy manufacturing: what do we want in the bag?

Cell collections destined for cell therapy manufacturing present many challenges to the manufacturer. A physician and two cell collection and manufacturing experts will share their perspective and experience related to starting material consistency, process challenges and bottlenecks, implications for the final product and key considerations for optimization. We will discuss different collection protocols to better define the starting material requirements and relevance to the cell and gene therapy manufacturer. We’ll also cover other factors that contribute to a robust and reproducible cell collection to meet manufacturing requirements.

Attendees will:

  • Learn what researchers need in their cell collection bag versus what they are getting
  • Understand how to optimize cell collections for cell therapy manufacturing and what the key considerations are for the final product
  • Review the available protocols for cell collections and understand their relevance to the cell therapy manufacturer
  • See how influencing standardization and consistency of starting material can be advantageous
Elizabeth Valdez, RN, MSN

Elizabeth Valdez, RN, MSN

Global Product Support and Training Specialist, Terumo BCT

Elizabeth Valdez is a Global Product Support and Training Specialist for the Therapeutic Systems team at Terumo BCT, manufacturer of the Spectra Optia® Apheresis System. She develops, maintains and conducts global training for Spectra Optia and other Terumo BCT products. Prior to working at Terumo BCT, Elizabeth was an Apheresis RN specializing in pediatric apheresis. She has conducted many educational sessions on the care of pediatric patients in the apheresis clinic and continues to look for avenues to educate clinicians about apheresis.

Krishnendu Roy, PhD

Krishnendu Roy, PhD

Director, NSF Engineering Research Centre for Cell Manufacturing Technologies (CMaT); Director, Marcus Center for Therapeutic Cell Characterization and Manufacturing (MC3M); Georgia Tech and Emory University

Dr. Roy’s research interests are in the areas of scalable cell manufacturing, immunoengineering, stem-cell engineering, and controlled drug and vaccine delivery technologies, with a particular focus in biomaterials. In recognition of his seminal contributions to these fields, Dr. Roy has been elected Fellow of the American Institute for Medical and Biological Engineering (AIMBE) and Fellow of the Biomedical Engineering Society (BMES). In addition, Dr. Roy has received numerous awards and honors, including Young Investigator Awards from both the Controlled Release Society (CRS) and the Society for Biomaterials (SFB), the NSF CAREER award, and the Global Indus Technovator Award from MIT, among others. He serves on the editorial boards of the Journal of Controlled Release, the European Journal of Pharmaceutics and Biopharmaceutics, the Journal of Immunology and Regenerative Medicine, and AIChE Journal of Advanced Manufacturing and Processing. He is also a member of the Forum on Regenerative Medicine of the National Academies of Science, Engineering and Medicine (NASEM) and a board member of the newly established Standards Coordinating Body (SCB) for Cell and Regenerative Therapies.

Jim Beltzer, PhD

Jim Beltzer, PhD

Senior Manager, Global Strategic Medical Affairs, Terumo BCT

Jim earned his PhD in Biochemistry at Purdue University and did his post-doctoral fellowship at the Biocenter in Basel, Switzerland. He worked at several start-up biotechnology companies in the Boston area and at Corning Life Sciences prior to joining the Cell Processing team at Terumo BCT. He has more than twenty five years of research and development experience in a broad range of disciplines.

Sandeep Soni, MD

Sandeep Soni, MD

Executive Director, Clinical Development, Crispr Therapeutics, Inc

Sandeep Soni, MD has 16 years’ experience in management of patients undergoing stem cell transplants, with hemoglobinopathies and bone marrow failure as niche areas of expertise. He is experienced in the design, management and regulatory requirements for multi-center gene-therapy trials and Phase I studies and is well acquainted with immune effector cell therapies and alternative donor HSCT options. Dr Soni is actively involved with ASTCT, ISCT and FACT. He is currently co-chair of ISCT’s immune cell and gene therapy committee. Dr Soni’s previous affiliations include the Lucile Packard Children’s Hospital at Stanford University and bluebird bio, Inc.

Melinda Caltabiano

Melinda Caltabiano

Director, Apheresis Operations, Dendreon

Melinda Caltabiano joined Dendreon in 2017 as Director of Apheresis Operations overseeing Dendreon’s expansive apheresis collection network throughout the United States. She ensures patients have convenient access to cell collection in their communities to facilitate their cancer treatment. She is also partnering with her Dendreon colleagues in China to help grow their apheresis network and bring Dendreon’s life-extending cancer treatment to Asia for men suffering from prostate cancer. Prior to joining Dendreon, Catalbiano spent more than 20 years at New York Blood Center as Director of Clinical Services. She also served in the United States Peace Corps in Slovakia for two years working on local environmental projects and youth development programs. Currently, she serves as Secretary of the Board of Directors for Be The Match and sits on the Diversity and Healthcare Disparities Advisory Group. She holds a bachelor’s degree from Manhattan College and a master’s degree in public administration from New York University’s Robert F. Wagner Graduate School of Public Service.

SPEAKERS

Elizabeth Valdez
Elizabeth Valdez
RN & MSN Global Trainer at Terumo BCT
Jim Beltzer
Jim Beltzer
Global Strategy Lead, Cell Therapy at TerumoBCT
Sandeep Soni
Sandeep Soni
Associate Professor, Pediatric Stem Cell Transplant, Gene Therapy & Regenerative Medicine at Stanford University School of Medicine
Melinda Caltabiano
Melinda Caltabiano
Director, Apheresis Operations at Dendreon Pharmaceuticals
Krishnendu Roy
Krishnendu Roy
Professor, Director, Marcus Center for Therapeutic Cell Characterization & Manufacturing (MC3M) at Georgia Institute of Technology

You might also like